![IJMS | Free Full-Text | Induced Coma, Death, and Organ Transplantation: A Physiologic, Genetic, and Theological Perspective IJMS | Free Full-Text | Induced Coma, Death, and Organ Transplantation: A Physiologic, Genetic, and Theological Perspective](https://pub.mdpi-res.com/ijms/ijms-24-05744/article_deploy/html/images/ijms-24-05744-g001.png?1679041660)
IJMS | Free Full-Text | Induced Coma, Death, and Organ Transplantation: A Physiologic, Genetic, and Theological Perspective
![Repair of Retinal Degeneration following Ex Vivo Minicircle DNA Gene Therapy and Transplantation of Corrected Photoreceptor Progenitors - ScienceDirect Repair of Retinal Degeneration following Ex Vivo Minicircle DNA Gene Therapy and Transplantation of Corrected Photoreceptor Progenitors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001620300551-fx1.jpg)
Repair of Retinal Degeneration following Ex Vivo Minicircle DNA Gene Therapy and Transplantation of Corrected Photoreceptor Progenitors - ScienceDirect
![Combining cell transplantation and gene therapy to enhance axonal outgrowth in the central nervous system|News and Events | CiRA | Center for iPS Cell Research and Application, Kyoto University Combining cell transplantation and gene therapy to enhance axonal outgrowth in the central nervous system|News and Events | CiRA | Center for iPS Cell Research and Application, Kyoto University](https://www.cira.kyoto-u.ac.jp/assets_c/2023/04/20230406_jtakahashi_en.jpg)
Combining cell transplantation and gene therapy to enhance axonal outgrowth in the central nervous system|News and Events | CiRA | Center for iPS Cell Research and Application, Kyoto University
![NIH researchers create new viral vector for improved gene therapy in sickle cell disease | National Institutes of Health (NIH) NIH researchers create new viral vector for improved gene therapy in sickle cell disease | National Institutes of Health (NIH)](https://www.nih.gov/sites/default/files/styles/featured_media_breakpoint-medium/public/news-events/news-releases/2019/20191002-sickle-cell.jpg?itok=vNwsRRC6×tamp=1570018155)
NIH researchers create new viral vector for improved gene therapy in sickle cell disease | National Institutes of Health (NIH)
![IJMS | Free Full-Text | Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder? IJMS | Free Full-Text | Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?](https://www.mdpi.com/ijms/ijms-23-04854/article_deploy/html/images/ijms-23-04854-g001.png)
IJMS | Free Full-Text | Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
![The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing - The Lancet Haematology The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing - The Lancet Haematology](https://www.thelancet.com/cms/asset/7d5fa2b0-87f3-4b94-9eab-1306d5685eb3/gr1.jpg)
The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing - The Lancet Haematology
![StudyPages - Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant StudyPages - Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant](https://yuzu-studypages-prod-east.s3.amazonaws.com/study_banners/473.jpg)